EUVIMEDEUVIMED entdecken
Open Access

Effectiveness and challenges of DOT in multidrug-resistant TB: a 12-year retrospective study

S Jabeen, S Memon, F Rashid, N Ahmed, M N Khan, S M Qadir, M Akram, N Ahmed, A W Khan, Y Fu, F Zhang

Public Health Action · 2026-05 · 16 (2) · 75-80

DOI: 10.5588/pha.25.0057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Action, online erschienen am 01.05.2026. Verfasst von S Jabeen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Wu Lien Teh Institute, Harbin Medical University, Harbin, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SETTING TB remains a major public health problem in Pakistan, a high-burden country with a high prevalence of multidrug-resistant TB (MDR-TB). Directly Observed Treatment (DOT) is widely used to improve treatment adherence; however, provincial-level evaluations remain limited, particularly in Sindh. OBJECTIVE To assess the effectiveness, outcomes, and challenges of DOT in Sindh Province over a 12-year period. A retrospective observational study was conducted including all patients enrolled in the National DOT Programme in Sindh from 2010 to 2022. Demographic, clinical, and treatment data were evaluated. RESULTS Pulmonary MDR-TB was highly prevalent among individuals aged 16–35 years. Extensively drug-resistant TB (XDR-TB) accounted for 6.32% of cases and pan drug-resistant TB (PDR-TB) for 0.32%. Before enrolling into DOT, most patients (48.35%) had treatment outcomes that were not evaluated or had failed treatment (38.45%) in their previous non-DOT therapy. DOT achieved cure rates of 68% for long-term regimens and 75% for short-term regimens, with timely sputum conversion. CONCLUSION DOT was effective for managing MDR-TB; however, high MDR-TB prevalence, delayed diagnosis, treatment-related side effects, and patient loss to follow-up emphasise the need for strengthened early detection, adherence support, and monitoring strategies to improve treatment outcomes.

Schlagwörter

Stichwörter der Autor:innen

MDR-TBPakistanSindhdirectly observed therapylong-term regimenshort-term regimentreatment outcomestuberculosis

Autor:innen und Institutionen

  • Department of Microbiology, Wu Lien Teh Institute, Harbin Medical University, Harbin, China.
  • Institute of Health, Kunming Medical University, Kunming, China.
  • Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, Pakistan.
  • National Reference Laboratory for Tuberculosis, National TB Control Program, Islamabad, Pakistan.
  • Department of Cell Biology and Genetics, Shantou University Medical College, Shantou, China.
  • Department of Life Sciences, School of Science (SSC), University of Management and Technology, Lahore, Pakistan.

Zitieren

APA

Jabeen, S., Memon, S., Rashid, F., Ahmed, N., Khan, M. N., Qadir, S. M., Akram, M., Ahmed, N., Khan, A. W., Fu, Y., & Zhang, F. (2026). Effectiveness and challenges of DOT in multidrug-resistant TB: a 12-year retrospective study. Public Health Action, 16(2), 75-80. https://doi.org/10.5588/pha.25.0057

Vancouver

Jabeen S, Memon S, Rashid F, Ahmed N, Khan MN, Qadir SM, et al. Effectiveness and challenges of DOT in multidrug-resistant TB: a 12-year retrospective study. Public Health Action. 2026;16(2):75-80. doi:10.5588/pha.25.0057

BibTeX
@article{Jabeen2026,
  author = {Jabeen, S and Memon, S and Rashid, F and Ahmed, N and Khan, M N and Qadir, S M and Akram, M and Ahmed, N and Khan, A W and Fu, Y and Zhang, F},
  title = {Effectiveness and challenges of DOT in multidrug-resistant TB: a 12-year retrospective study},
  journal = {Public Health Action},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {75--80},
  doi = {10.5588/pha.25.0057}
}
Kostenlos starten →